Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Philadelphia Academic Health System was a Philadelphia-based hospital operating company that owned Hahnemann University Hospital and St. Christopher’s Hospital for Children. The entity functioned as a healthcare services and hospital ownership platform rather than a drug-development biotech or pharma company. PAHS filed for Chapter 11 bankruptcy on June 30, 2019, after announcing the wind-down and closure of Hahnemann, while pursuing a restructuring and sale process for St. Christopher’s. The business was a subsidiary of Philadelphia Academic Health Holdings and was associated with the broader American Academic Health System/Paladin Healthcare network. It is best understood as a former provider-side healthcare operator with no disclosed therapeutic pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Philadelphia Academic Health System.